Massimo Serra

Has grant

Chief of the "Pharmacogenomics and Pharmacogenetics" Research Unit (Struttura Semplice)

IRCCS Istituto Ortopedico Rizzoli
Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

BRCAddict-Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors

Open Date: 2019-07-01

Close Date: 2022-07-01

Grant: Close

Toward tailored treatments for osteosarcoma through validation of pharmacogenomic markers

Open Date: 2019-01-01

Close Date: 2024-01-01

Grant: Close

Efficacy assessment of new targeted combination therapies for musculoskeletal sarcomas as the basis for tailoring patients' treatment

Open Date: 2018-10-01

Close Date: 2022-02-01

Grant: Close

Cisplatin resistance in osteosarcoma: Validation of new therapeutic targets and drugs for tailored clinical approaches

Open Date: 2015-01-01

Close Date: 2017-12-01

Grant: Close

Cisplatin resistance in osteosarcoma: Validation of new therapeutic targets and drugs for tailored clinical approaches

Open Date: 2015-01-01

Close Date: 2017-12-01

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Chiara Riganti

tenured assistant professor

University of Turin

ITALY
View details

Francesca Cordero

Associate Professor

University of Turin

ITALY
View details

Adrienne M Flanagan

-

UNITED KINGDOM
View details

Joanna Kopecka

University of Turin

ITALY
View details

Anastasia De Luca

University of Rome Tor Vergata

ITALY
View details

Maria Pia Patrizio

IRCCS Istituto Ortopedico Rizzoli

ITALY
View details

Federica Di Nicolantonio

-

ITALY
View details

Roelof Koster

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

NETHERLANDS
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.